Celadon Pharmaceuticals PLC (GB:CEL) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Celadon Pharmaceuticals is navigating financial uncertainties as it awaits £0.5 million from its credit facility, contingent on an investment sale by its lender. With current cash reserves of £0.3 million, the company expects to sustain operations until January 2025 and is exploring alternative financing options to secure its future.
For further insights into GB:CEL stock, check out TipRanks’ Stock Analysis page.
